| Name: |
|
| Other Names: |
|
|
Classification:
|
|
|
Mechanism of Action:
|
- Increases blood glucose levels
- Hypertonic solution producing a transient movement of water from interstitial spaces into the venous system
|
|
Indications:
|
- Hypoglycemia (< 4.0 mmol/L who are unable to take oral glucose)
|
|
Contraindications:
|
|
|
Precautions:
|
- Tissue necrosis if infiltration occurs
- May precipitate severe neurological symptoms in alcoholics (thiamine should be consider prior to administration)
- Patients with increased intracranial pressure may worsen cerebral edema
|
|
Adverse Effects:
|
- Phlebitis
- Tissue necrosis
- Rebound hyperglycemia
|
|
Dose:
|
|
|
Adult:
|
- 25 g IVP, may repeat once if symptoms do no resolve and glucometer reading remains less than 4.0 mmol/L
|
|
Pediatric:
|
- 0.5 - 1 g/kg slow IVP; dilute 1:1 with sterile water (NS can be used if no sterile water available) forming D25W
- May repeat once
- Maximum total dose of 25 g
|
| Routes: |
|
| Special Notes: |
- To make a D25W solution from D50W:
- Dispose of 25 mL of the D50W solution from the preloaded syringe and replace with 25 mL of normal saline.
OR
-
- Draw 25 mL of the D50W solution from the 50 mL vial using a 50 mL syringe and vial access spike, then add 25 mL of normal saline.
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Professional 2nd Edition
|
Modifié le: dimanche, 16 mars 2025, 20:57